Vanguard Group
PHVS icon

Vanguard Group’s Pharvaris PHVS Stock Holding History

Vanguard Group’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$536K Hold
19,310
– – ﹤0.01% 3927
2025
Q3 		$482K Buy
+19,310
New +$428K ﹤0.01% 3958
2025
Q2 		– Sell
-12,740
Closed -$200K – 4312
2025
Q1 		$200K Hold
12,740
– – ﹤0.01% 4075
2024
Q4 		$244K Hold
12,740
– – ﹤0.01% 4070
2024
Q3 		$236K Buy
+12,740
New +$233K ﹤0.01% 4106

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group's PHVS Position: Q4 2025 in Review

Vanguard Group held its Pharvaris (PHVS) position steady in Q4 2025 at 19,310 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.

Vanguard Group first reported a position in PHVS in Q3 2024 and has held it in 5 quarters since. 106 funds tracked by Wall St. Rank hold PHVS as of Q4 2025.

  • Vanguard Group held 19,310 shares of Pharvaris worth $536K as of Q4 2025.
  • Vanguard Group left its Pharvaris share count unchanged in Q4 2025.
  • Pharvaris made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3927 holding.
  • Vanguard Group first reported a position in Pharvaris in Q3 2024 and has held it in 5 quarters since.
  • 106 funds tracked by Wall St. Rank held Pharvaris as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.